Connect with us

MAM

P&G India extends all company benefits to partners of LGBTQ+ employees

Published

on

Mumbai: In a bid to foster inclusivity at the workplace, Procter & Gamble (P&G) has now extended all its company offered benefits to partners of LGBTQ+ employees, the company announced on Tuesday. Effective 1 April, the company’s medical and workplace benefits including medical support, emergency financial assistance, flex subsidy allowance, relocation benefits, among others will be extended to partners of LGBTQ+ employees.

The initiative builds on top of the company’s ‘Share the Care’ inclusive parental leave policy that was launched last year.

“At P&G, our goal is to create a fully inclusive workplace where our employees feel included and are able to bring their authentic selves to work every day,” said Procter & Gamble Indian sub-continent vice president and head – human resources PM Srinivas. “In line with that, we are proud to shape our company offered comprehensive benefits to a fully inclusive and equality-based program which extends to partners of LGBTQ+ employees. We will also continue to strengthen our awareness and training programs that sensitize our people on LGBTQ+ diversity. We hope that this will enable us to strengthen our company’s culture, inspire change and create a positive societal impact.”

Advertisement

Through this latest initiative, partners of LGBTQ+ employees will now be covered under the company’s medical plan that provides hospitalisation coverage to employees and their dependents. The employees can also avail emergency financial assistance for their partners. The company provides an additional fixed allowance to its employees to meet their personal and family needs, which can now be availed by LGBTQ+ employees for their partners. The company will also extend financial support and transfer related assistance arising out of a company-initiated relocation to partners of LGBTQ+ employees, said the statement.

According to the company, P&G took a public stand for inclusion by adding sexual orientation to its non-discrimination policies back in 1992. The company has an internal affinity group, GABLE (Gay, Ally, Bisexual, Lesbian, and Transgender Employees) that is dedicated to fostering an inclusive and supportive network.

P&G India has also launched ‘Pride Podcasts’ wherein it invites leaders from within P&G globally and external advocates who are sharing their journey, educating, and addressing myths about LGBTQ+. In a first, in 2021 the company organised a virtual pride event titled ‘PrideON’ to educate and celebrate the progress made on LGBTQ+ equality and inclusion in the workplace, according to the company.

Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

MAM

Beacon Group appoints Dr Rajesh Patel as Group CEO

36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.

Published

on

MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.

In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.

The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.

Advertisement

Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.

For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.

Advertisement
Continue Reading

Advertisement News18
Advertisement
Advertisement Whtasapp
Advertisement Year Enders

Indian Television Dot Com Pvt Ltd

Signup for news and special offers!

Copyright © 2026 Indian Television Dot Com PVT LTD